Published on September 14, 2012 at 1:08 AM
Neuralstem, Inc. (NYSE MKT: CUR) today announced the pricing of a registered direct offering of 7,000,000 shares of its common stock, offered at a price to the public of $1.00 per share.
The gross proceeds to Neuralstem from this offering are expected to be $7.0 million, before deducting placement agent fees and other estimated offering expenses payable by Neuralstem. The offering is expected to close on or about September 19, 2012, subject to customary closing conditions.
SOURCE Neuralstem, Inc.
c85f6221-b45f-48c6-bca1-ea2d4212731f|0|.0
Posted in: Business / Finance
Tags: Alzheimer's Disease, Anxiety, Brain, Cell, Encephalopathy, Lou Gehrig's Disease, Nervous System, Paraplegia, Spinal Cord Injury, Stem Cell, Stress, Stroke